Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

News

QualityStocks News - Immune Therapeutics (IMUN) Armed with Expertise in the Immune System to Fight Infectious Diseases

Scottsdale 3/18/2016 8:00:00 PM

QualityStocks would like to highlight Immune Therapeutics, Inc. (OTCQB: IMUN), a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect persons around the world. Building on the power of the body’s natural immune system, the company’s pipeline of products and immunotherapy technologies are designed to enhance treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

In the company’s news,

Immune Therapeutics, Inc. (OTCQB: IMUN) centers its works on applying its patented immunotherapy to fight chronic diseases, such as cancer, which affect people of all ages and races all over the world. Leveraging the body’s natural immune system, the company’s product line and immunotherapy technologies are engineered to enhance treatment for those suffering with HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

One of IMUN’s promising treatments is Low Dose Naltrexone (LDN), or Lodonal, as it is known on a global scale. Lodonal has its origins in the FDA-approved 50mg Naltrexone. Initially known to treat opiate dependencies, the Immune Therapeutics patented treatment, which covers a wide range of indications, is currently used as an immune modulator. Lodonal /LDN works by boosting levels of endorphins (peptides produced in the brain and adrenal glands). These natural peptides are very effective modulators of the immune system. When patients take Lodonal, it attaches to opioid receptors in the brain and immune cells and temporarily blocks endorphins signaling the body in order to increase endorphin production. The increased endorphin production facilitates the activity of stem cells, macrophages, natural killer cells, T and B cells and other immune cells. Lodonal is also effective in preventing immune system over activity, the core of autoimmune disorders, and reduces the release of inflammatory and neurotoxic chemicals in the brain.

New York physician Dr. Bernard Bihari, who has studied immune responses primarily in HIV/AIDs patients, has produced a three-point mechanistic approach to the use of LDN showing the following three distinct increases within the immune system. The first increase is within met-enkephalin (an endorphin produced in large amounts in the adrenal medulla) and endorphin in the blood stream. The second increase occurs within the number and density of opiate receptors on the tumor cell membranes, thereby making them more responsive to the growth-inhibiting effects of the already present levels of endorphins, which in turn induces apoptosis in the cancer cells. Third, increases are stimulated within absolute numbers of circulating cytotoxic T cells (CD8+/TH1) and natural killer cells (“NK cells”), as well as NK cell activity.

IMUN focuses on the development and commercialization of therapeutic treatments for cancer, HIV/AIDS, autoimmune diseases, and immune disorders in the United States. Currently, the company is developing IRT-101, an active immunotherapy systemic administration of methionine-enkephalin that works by stimulating a patient’s immune system against infectious diseases, autoimmune diseases, immune disorders, and tumor cells. The company is headquartered in Orlando, Florida.

About QualityStocks


QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net  

To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage

To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net   

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

More News

QualityStocks News - Giggles N’ Hugs (GIGL) Delivers Nutritional Menu while Captivating the Small Mall Visitor


Released On: 4/6/2016
Views: 4975

QualityStocks News - Laguna Blends (LAGBF) Adds Pro369 Hemp Protein Product to Affiliate Program


Released On: 4/5/2016
Views: 5506

QualityStocks News - Alternet Systems (ALYI) Big Data Division Helps Clients to the Cloud


Released On: 4/1/2016
Views: 5729

QualityStocks News - Agora Holdings (AGHI) Develops TECH – a Workflow Management Software for Small- to Medium-Sized Businesses


Released On: 3/30/2016
Views: 3261

QualityStocks News - Giggles N’ Hugs, Inc. (GIGL) – Investing in Opportunities for Smart Growth


Released On: 3/29/2016
Views: 4654

QualityStocks News - Star Mountain Resources (SMRS): Gold has a Shimmering Start in 2016


Released On: 3/23/2016
Views: 3358

QualityStocks News - Immune Therapeutics (IMUN) Armed with Expertise in the Immune System to Fight Infectious Diseases


Released On: 3/18/2016
Views: 4683

QualityStocks News - Orphan Drug Status for RPI-78M Boosts Nutra Pharma Corp.’s (NPHC) IP Portfolio


Released On: 3/16/2016
Views: 3566

QualityStocks News - Halitron (HAON) Pursuing Rapid Growth through Acquisition-Based Business Model


Released On: 3/15/2016
Views: 4123

QualityStocks News - The Giggles N’ Hugs (GIGL) Team has Franchising on Its Mind


Released On: 3/10/2016
Views: 3804

QualityStocks News - Dominovas Energy (DNRG): Report Forecasts 50% Growth in SOFC Market By 2020


Released On: 3/9/2016
Views: 3063

QualityStocks News - FlexWeek (FXWK) taps the Access Economy with its Peer-to-Peer Timeshare Rental Platform


Released On: 3/8/2016
Views: 3235

QualityStocks News - Alternet Systems (ALYI) Mining Shareholder Value in Age of Information Overload


Released On: 3/2/2016
Views: 2869

QualityStocks News - Agora Holdings (AGHI) Announces Release of Enhanced FRAME Social Media Management Software for Business Use


Released On: 3/1/2016
Views: 4141

QualityStocks News - Star Mountain Resources (SMRS) Stands to Reap the Rewards of Last Year’s Business Acquisition


Released On: 2/25/2016
Views: 2647

QualityStocks News - Immune Therapeutics, Inc. (IMUN) is “One to Watch”


Released On: 2/24/2016
Views: 2846

QualityStocks News - Nutra Pharma Corporation (NPHC) Presenting at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference


Released On: 2/19/2016
Views: 7779

QualityStocks News - GTX Corp. (GTXO) Has You Covered 24/7 with Expert GPS Monitoring Technology


Released On: 2/18/2016
Views: 2858

Load More wait

Map

Quality Stocks

Get Directions

Quality Stocks

  • 3370 N. Hayden Rd., Suite 123-591
    Scottsdale, Arizona 85251
    United States
  • 480-374-1336
  • Monday through Friday